Work

Cost Effectiveness Analysis of Enzalutamide, Abiraterone Plus Prednisone and Cabazitaxel Plus Predinsone for the Treatment of Visceral Metastatic Castration Resistant Prostate Cancer (mcrpc) After Docetaxel Therapy

Year: 2018

Type: article

Source: UNM’s Digital Repository (University of New Mexico)

Author: Yazan K. Barqawi

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2961844706

FWCI:

Cites: 96

Cited by:

Related to: 10